Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

435.06 -4.31 (-0.98%)
Streaming Delayed Price Updated: 3:14 PM EDT, May 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
61 62 Next >
3 Top Biotech Stocks Defying the Bear Market
Each has the potential to dramatically outperform the market. 
Via The Motley Fool
3 Biotech Stocks to Buy for Long-Term Gains
The biotech sector is one of the most volatile sectors, but here are three biotech stocks that offer opportunities for patient biotech stock investors. 
Via MarketBeat
Topics ETFs Economy
Exposures Interest Rates
Got $500? 3 Growth Stocks to Buy That Could Double Your Money
There's no guarantee these stocks will deliver 2x returns over the next few years, but their prospects look good. 
Via The Motley Fool
3 Biotech Stocks That AI is Loving in July
As AI becomes a more entrenched aspect of society, investors can lean on these AI recommended biotech stocks with predicted high potential. 
Via InvestorPlace
3 Things About Vertex Pharmaceuticals That Smart Investors Know
Vertex shares have advanced about 20% so far this year. 
Via The Motley Fool
Here's How Much $1000 Invested In Vertex Pharmaceuticals 20 Years Ago Would Be Worth Today
Via Benzinga
Peering Into Vertex Pharmaceuticals's Recent Short Interest
Via Benzinga
Vertex Pharmaceuticals Stock: Bear vs. Bull
Vertex has reached a key moment in its story. 
Via The Motley Fool
2 Top Healthcare Stocks Defying the Bear Market
These stocks are rising in the double digits -- and outperforming the S&P 500. 
Via The Motley Fool
Sitting on Cash? These 2 Stocks Are Great Buys
Coca-Cola and Vertex Pharmaceuticals are excellent choices to add to your portfolio for the long term. 
Via The Motley Fool
Is Johnson & Johnson Stock a Buy Now?
Some businesses never go out of style. 
Via The Motley Fool
Want to Get Richer? 2 Unstoppable Stocks to Invest $1,000 In This Week
A tech giant and a biotech standout are both proving their mettle in 2023. 
Via The Motley Fool
3 Growth Stocks With 55% to 71% Upside, According to Wall Street
Find out why investment bank analysts are so bullish on these stocks. 
Via The Motley Fool
3 No-Brainer Stocks You Can Buy Right Now
Going with these stocks is an easy decision. 
Via The Motley Fool
$100 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Analyst Ratings for Vertex Pharmaceuticals
Via Benzinga
Delta Air Lines, Vertex Pharmaceuticals, And A Major US Bank Nearing A Breakout Level: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Amy Raskin of Chevy Chase Trust said Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), has 
Via Benzinga
2 Growth Stocks That Might Be Too Cheap to Ignore
The sky is the limit for these healthcare companies. 
Via The Motley Fool
2 Supercharged Growth Stocks to Invest In Before the Next Bull Market
Whatever the market does in the next few months, these stocks have plenty of room left to run. 
Via The Motley Fool
3 Biotech Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2025
In researching this article, we used AI to help make predictions for potential triple-digit return biotech stocks by 2025 
Via InvestorPlace
The 3 Best Biotech Stocks to Buy In July
With these companies fueling sales and earnings with medical innovations and breakthroughs, they may be the best biotech stocks to pick up. 
Via InvestorPlace
Vertex to Announce Second Quarter 2023 Financial Results on August 1
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Verve Therapeutics Gains 20.74% In June as Ark Funds Invest
Verve Therapeutics' efforts to eliminate cardiovascular disease through gene-editing treatments have momentum, as the stock gets a 20.74% boost in June. 
Via MarketBeat
Buying These 3 Stocks Could Be the Smartest Investing Move You'll Ever Make
Buying these stocks now could pay off handsomely over the long run. 
Via The Motley Fool
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
Both companies have therapies that should help grow revenue and earnings for years. 
Via The Motley Fool
Large Cap Biopharma Buffeted By Big Gov, Choppy Days Ahead
After a huge run-up in stocks since January investors have come to realize that most of the gains have come from the so-called “Magnificent Seven” tech stocks. 
Via Talk Markets
Vertex and Lonza to Build Dedicated Manufacturing Facility for Type 1 Diabetes (T1D) Cell Therapies
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Vertex Presents Positive VX-880 Results From Ongoing Phase 1/2 Study in Type 1 Diabetes at the American Diabetes Association 83rd Scientific Sessions
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Alleged Industrial Espionage Makes an Interesting Story
We also chat about Vertex Pharmaceuticals and its role at the center of cystic fibrosis treatment. 
Via The Motley Fool
Buying This Growth Stock Hand-Over-Fist Right Now Could Make You a Lot Wealthier by 2030
This company has several catalysts for growth coming up, with more on the way. 
Via The Motley Fool
< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
61 62 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.